Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108
   PubMed Web of Science ®Google Scholar
• Franckena M, De Wit R, Ansink AC, Notenboom A, Canters RA, Fatehi D, et al. Weekly systemic cisplatin plus locoregional hyperthermia: An effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area. Int J Hyperthermia 2007;23:443–50
   PubMed Web of Science ®Google Scholar
• Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005;3:CD002225
   Google Scholar
• Muggia FM, Blessing JA, Waggoner S, Berek JS, Monk BJ, Sorosky J, et al. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 2005;96:108–11
   PubMed Web of Science ®Google Scholar
• Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman LD. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 2009;27:1069–74
   PubMed Web of Science ®Google Scholar
• Muggia FM, Blessing JA, McGehee R, Monk BJ. Cisplatin and irinotecan in squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group. Gynecol Oncol 2004;94:483–7
   PubMedGoogle Scholar
• Pectasides D, Fountzilas G, Papaxoinis G, Pectasides E, Xiros N, Sykiotis C, et al. Carboplatin and paclitaxel in metastatic or recurrent cervical cancer. Int J Gynecol Cancer 2009;19:777–81
   PubMedGoogle Scholar
• Kitagawa R, Katsumata N, Ando M, Shimizu C, Fujiwara Y, Yoshikawa H, et al. A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer. Gynecol Oncol 2012;125:307–11
   PubMedGoogle Scholar
• Long HJ III, Bundy BN, Grendys EC Jr, Benda JA, McMeekin DS, Sorosky J, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A Gynecologic Oncology Group study. J Clin Oncol 2005;23:4626–33
   PubMed Web of Science ®Google Scholar
• Moore KN, Herzog TJ, Lewin S, Giuntoli RL, Armstrong DK, Rocconi RP, et al. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol Oncol 2007;105:299–303
   PubMed Web of Science ®Google Scholar
• Gynecologic Oncology Group. Paclitaxel and cisplatin or topotecan with or without bevacizumab for treating patients with stage IVB, recurrent, or persistent cervical cancer. [Abstract]. ASCO Annual Meeting, Chicago, IL, 31 May-4 June, 2013
   Google Scholar
• Rietbroek RC, Schilthuis MS, Bakker PJ, van Dijk JD, Postma AJ, Gonzalez Gonzalez D, et al. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 1997;79:935–43
   PubMed Web of Science ®Google Scholar
• de Wit R van der Zee J, van der Burg ME, Kruit WH, Logmans A, van Rhoon GC, et al. A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer 1999;80:1387–91
   PubMed Web of Science ®Google Scholar
• Richel O, Zum Vorde Sive Vording PJ, Rietbroek R, Van der Velden J, Van Dijk JD, Schilthuis MS, et al. Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer. Gynecol Oncol 2004;95:680–5
   PubMed Web of Science ®Google Scholar
• Haasbeek CJ, Uitterhoeve AL, van der Velden J, Gonzalez DG, Stalpers LJ. Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery. Radiother Oncol 2008;89:197–204
   PubMed Web of Science ®Google Scholar
• Juffermans JH, Hanssens PE, van Putten WL, van Rhoon GC, van Der Zee J. Reirradiation and hyperthermia in rectal carcinoma: A retrospective study on palliative effect. Cancer 2003;98:1759–66
   PubMedGoogle Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355(9210):1119–25
   PubMed Web of Science ®Google Scholar